106 related articles for article (PubMed ID: 11724300)
1. Implication of the proliferation and apoptosis associated CSE1L/CAS gene for breast cancer development.
Behrens P; Brinkmann U; Fogt F; Wernert N; Wellmann A
Anticancer Res; 2001; 21(4A):2413-7. PubMed ID: 11724300
[TBL] [Abstract][Full Text] [Related]
2. High expression of the proliferation and apoptosis associated CSE1L/CAS gene in hepatitis and liver neoplasms: correlation with tumor progression.
Wellmann A; Flemming P; Behrens P; Wuppermann K; Lang H; Oldhafer K; Pastan I; Brinkmann U
Int J Mol Med; 2001 May; 7(5):489-94. PubMed ID: 11295109
[TBL] [Abstract][Full Text] [Related]
3. CSE1L/CAS: its role in proliferation and apoptosis.
Behrens P; Brinkmann U; Wellmann A
Apoptosis; 2003 Jan; 8(1):39-44. PubMed ID: 12510150
[TBL] [Abstract][Full Text] [Related]
4. The hCSE1/CAS protein is phosphorylated by HeLa extracts and MEK-1: MEK-1 phosphorylation may modulate the intracellular localization of CAS.
Scherf U; Kalab P; Dasso M; Pastan I; Brinkmann U
Biochem Biophys Res Commun; 1998 Sep; 250(3):623-8. PubMed ID: 9784396
[TBL] [Abstract][Full Text] [Related]
5. The cellular apoptosis susceptibility CAS/CSE1L gene protects ovarian cancer cells from death by suppressing RASSF1C.
Lorenzato A; Martino C; Dani N; Oligschläger Y; Ferrero AM; Biglia N; Calogero R; Olivero M; Di Renzo MF
FASEB J; 2012 Jun; 26(6):2446-56. PubMed ID: 22389439
[TBL] [Abstract][Full Text] [Related]
6. Localization of the cell proliferation and apoptosis-associated CAS protein in lymphoid neoplasms.
Wellmann A; Krenacs L; Fest T; Scherf U; Pastan I; Raffeld M; Brinkmann U
Am J Pathol; 1997 Jan; 150(1):25-30. PubMed ID: 9006318
[TBL] [Abstract][Full Text] [Related]
7. AKT activation drives the nuclear localization of CSE1L and a pro-oncogenic transcriptional activation in ovarian cancer cells.
Lorenzato A; Biolatti M; Delogu G; Capobianco G; Farace C; Dessole S; Cossu A; Tanda F; Madeddu R; Olivero M; Di Renzo MF
Exp Cell Res; 2013 Oct; 319(17):2627-36. PubMed ID: 23948303
[TBL] [Abstract][Full Text] [Related]
8. Cellular apoptosis susceptibility (chromosome segregation 1-like, CSE1L) gene is a key regulator of apoptosis, migration and invasion in colorectal cancer.
Alnabulsi A; Agouni A; Mitra S; Garcia-Murillas I; Carpenter B; Bird S; Murray GI
J Pathol; 2012 Dec; 228(4):471-81. PubMed ID: 22450763
[TBL] [Abstract][Full Text] [Related]
9. Increased cellular apoptosis susceptibility (CSE1L/CAS) protein expression promotes protrusion extension and enhances migration of MCF-7 breast cancer cells.
Tai CJ; Shen SC; Lee WR; Liao CF; Deng WP; Chiou HY; Hsieh CI; Tung JN; Chen CS; Chiou JF; Li LT; Lin CY; Hsu CH; Jiang MC
Exp Cell Res; 2010 Oct; 316(17):2969-81. PubMed ID: 20688056
[TBL] [Abstract][Full Text] [Related]
10. The human CAS (cellular apoptosis susceptibility) gene mapping on chromosome 20q13 is amplified in BT474 breast cancer cells and part of aberrant chromosomes in breast and colon cancer cell lines.
Brinkmann U; Gallo M; Polymeropoulos MH; Pastan I
Genome Res; 1996 Mar; 6(3):187-94. PubMed ID: 8963895
[TBL] [Abstract][Full Text] [Related]
11. Investigation of the Mek-MAP kinase-Rsk pathway in human breast cancer.
Salh B; Marotta A; Matthewson C; Ahluwalia M; Flint J; Owen D; Pelech S
Anticancer Res; 1999; 19(1B):731-40. PubMed ID: 10216485
[TBL] [Abstract][Full Text] [Related]
12. Abnormal expression of cell cycle regulatory proteins in ductal and lobular carcinomas of the breast.
Geradts J; Ingram CD
Mod Pathol; 2000 Sep; 13(9):945-53. PubMed ID: 11007034
[TBL] [Abstract][Full Text] [Related]
13. CAS (CSE1L) signaling pathway in tumor progression and its potential as a biomarker and target for targeted therapy.
Jiang MC
Tumour Biol; 2016 Oct; 37(10):13077-13090. PubMed ID: 27596143
[TBL] [Abstract][Full Text] [Related]
14. CAS (cellular apoptosis susceptibility) gene expression in ovarian carcinoma: Correlation with 20q13.2 copy number and cyclin D1, p53, and Rb protein expression.
Peiró G; Diebold J; Löhrs U
Am J Clin Pathol; 2002 Dec; 118(6):922-9. PubMed ID: 12472286
[TBL] [Abstract][Full Text] [Related]
15. Cellular apoptosis susceptibility protein and proliferation in human hepatocellular carcinoma.
Shiraki K; Fujikawa K; Sugimoto K; Ito T; Yamanaka T; Suzuki M; Yoneda K; Sugimoto K; Takase K; Nakano T
Int J Mol Med; 2006 Jul; 18(1):77-81. PubMed ID: 16786158
[TBL] [Abstract][Full Text] [Related]
16. CSE1L/CAS, the cellular apoptosis susceptibility protein, enhances invasion and metastasis but not proliferation of cancer cells.
Liao CF; Luo SF; Li LT; Lin CY; Chen YC; Jiang MC
J Exp Clin Cancer Res; 2008 Jul; 27(1):15. PubMed ID: 18597698
[TBL] [Abstract][Full Text] [Related]
17. Cellular apoptosis susceptibility protein (CAS) suppresses the proliferation of breast cancer cells by upregulated cyp24a1.
Ye M; Han R; Shi J; Wang X; Zhao AZ; Li F; Chen H
Med Oncol; 2020 Apr; 37(5):43. PubMed ID: 32270348
[TBL] [Abstract][Full Text] [Related]
18. Elevated NRD1 metalloprotease expression plays a role in breast cancer growth and proliferation.
Choong LY; Lim SK; Chen Y; Loh MC; Toy W; Wong CY; Salto-Tellez M; Shah N; Lim YP
Genes Chromosomes Cancer; 2011 Oct; 50(10):837-47. PubMed ID: 21769958
[TBL] [Abstract][Full Text] [Related]
19. Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast.
Tanaka T; Kimura M; Matsunaga K; Fukada D; Mori H; Okano Y
Cancer Res; 1999 May; 59(9):2041-4. PubMed ID: 10232583
[TBL] [Abstract][Full Text] [Related]
20. BRCA1-mediated G2/M cell cycle arrest requires ERK1/2 kinase activation.
Yan Y; Spieker RS; Kim M; Stoeger SM; Cowan KH
Oncogene; 2005 May; 24(20):3285-96. PubMed ID: 15735702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
